Stem cells and breast cancer: A field in transit

Nature Reviews Cancer

Volumn 3, Issue 11, 2003, Pages 832-844

  Smalley, Matthew ^a   Ashworth, Alan ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST DEVELOPMENT; CANCER PREVENTION; DRUG SCREENING; HISTOLOGY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE EXPANSION; TISSUE REGENERATION;

EID: 0242667837     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1212     Document Type: Review

References (80)

1. Seaberg, R. M. & Van Der Kooy, D. Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci. 26, 125-131 (2003).
2. Smith, C. Hematopoietic stem cells and hematopoiesis. Cancer Control 10, 9-16 (2003).
3. Galli, R. et al. Neural stem cells: an overview. Circ. Res. 92, 598-608 (2003).
4. Alonso, L. & Fuchs, E. Stem cells in the skin: waste not, Wnt not. Genes Dev. 17, 1189-1200 (2003).
5. Potten, C. S. & Loeffler, M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110, 1001-1020 (1990).
6. Potten, C. S. et al. The small intestine as a model for evaluating adult tissue stem cell drug targets. Cell Prolif. 36, 115-129 (2003).
7. Hedrick, S. M. T-cell development: bottoms-up. Immunity 16, 619-622 (2002).
8. Ohneda, K. & Yamamoto, M. Roles of hematopoietic transcription factors Gata-1 and Gata-2 in the development of red blood cell lineage. Acta Haematol. 108, 237-245 (2002).
9. Frye, M. et al. Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment. Development 130, 2793-2808 (2003). An important demonstration of how perturbation of the expression pattern of a single gene can affect the balance between stem and transit cells.
10. Owens, D. M. & Watt, F. M. Contribution of stem cells and differentiated cells to epidermal tumours. Nature Rev. Cancer 3, 444-451 (2003).
11. Morgan, J. E. & Partridge, T. A. Muscle satellite cells. Int. J. Biochem. Cell Biol. 35, 1151-1156 (2003).
12. Hawke, T. J. & Garry, D. J. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551 (2001).
13. Seale, P. & Rudnicki, M. A. A new look at the origin, function, and 'stem-cell' status of muscle satellite cells. Dev. Biol. 218, 115-124 (2000).
14. Williams, J. M. & Daniel, C. W. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev. Biol. 97, 274-290 (1983),
15. Srinivasan, K. et al. Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev. Cell 4, 371-382 (2003).
16. Debnath, J. et al. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268 (2003).
17. Smith, G. H. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res. Treat. 39, 21-31 (1996).
18. Kordon, E. C. & Smith, G. H. An entire functional mammary gland may comprise the progeny from a single cell. Development 125, 1921-1930 (1998). References 17 and 18 provide direct experimental evidence for the existence of dedicated mammary epithelial stem cells.
19. Wagner, K. U. et al. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 129, 1377-1386 (2002).
20. pos cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245, 42-56 (2002). This study was the first to demonstrate prospective enrichment of mammary epithelial cells for cells with stem-cell-like properties.
21. Naylor, S. et al. Retroviral expression of Wnt-1 and Wnt-7b produces different effects in mouse mammary epithelium. J. Cell Sci. 113, 2129-2138 (2000).
22. Diallo, R. et al. Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J. Pathol. 193, 27-32 (2001).
23. Chepko, G. & Dickson, R. B. Ultrastructure of the putative stem cell niche in rat mammary epithelium. Tissue Cell 35, 83-93 (2003).
24. Chepko, G. & Smith, G. H. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 29, 239-253 (1997).
25. Ellis, S. & Capuco, A. Cell proliferation in bovine mammary epithelium: identification of the primary proliferative cell population. Tissue Cell 34, 155 (2002).
26. Smith, C. A. et al. Basal clear cells of the normal human breast. Virchows Arch. A Pathol. Anat. Histopathol. 402, 319-329 (1984).
27. Smith, C. A. et al. Epithelial cells of the normal human breast. J. Pathol. 146, 221-226 (1985).
28. Ferguson, D. J. An ultrastructural study of mitosis and cytokinesis in normal 'resting' human breast. Cell Tissue Res. 252, 581-587 (1988). References 23-28 provide the basis for an understanding of the heterogeneity of the mammary epithelium and identify the basal clear cell as a putative stem cell.
29. Clarke, R. B. et al. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57, 4987-4991 (1997).
30. kip1 expression indicates that steroid receptor-positive cells are a non-proliferating, differentiated subpopulation of the normal human breast epithelium. Eur. J. Cancer 36, S28-S29 (2000).
31. Shoker, B. S. et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am. J. Pathol. 155, 1811-1815 (1999).
32. Zeps, N. et al. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation 62, 221-226 (1998).
33. Zeps, N. et al. Detection of a population of long-lived cells in mammary epithelium of the mouse. Cell Tissue Res. 286, 525-536 (1996).
34. O'Hare, M. J. et al. Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting. Differentiation 46, 209-221 (1991).
35. Pechoux, C. et al. Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev. Biol. 206, 88-99 (1999).
36. Stingl, J. et al. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 63, 201-213 (1998).
37. Stingl, J. et al. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 67, 93-109 (2001). References 35-37, together with reference 50, relate in situ heterogeneity of the breast epithelium to in vitro differentiative capacity.
38. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003).
39. Dundas, S. R. et al. Characterization of luminal and basal cells flow-sorted from the adult rat mammary parenchyma. J. Cell Sci. 100, 459-471 (1991).
40. Smalley, M. J. Cell Sorting and Clonal Analysis of Mouse Mammary Luminal Epithelial and Myoepithelial Cells. Thesis, Univ. London (1995).
41. Smalley, M. J. et al. Clonal characterization of mouse mammary luminal epithelial and myoepithelial cells separated by fluorescence-activated cell sorting. In Vitro Cell. Dev. Biol. Anim. 34, 711-721 (1998).
42. Smalley, M. J. et al. Differentiation of separated mouse mammary luminal epithelial and myoepithelial cells cultured on ehs matrix analyzed by indirect immunofluorescence of cytoskeletal antigens. J. Histochem. Cytochem. 47, 1513-1524 (1999).
43. Goodell, M. A. et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797-1806 (1996). The first description of the 'side population' phenomenon.
44. Zhou, S. et al. The ABC transporter BCRP1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Med. 7, 1028-1034 (2001).
45. Bunting, K. D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20, 11-20 (2002).
46. Bhattacharya, S. et al. Direct identification and enrichment of retinal stem cells/progenitors by Hoechst dye efflux assay. Invest. Ophthalmol. Vis. Sci. 44, 2764-2773 (2003).
47. Kubota, H. et al. Spermatogonial stem cells share some, but not all, phenotypic and functional characteristics with other stem cells. Proc. Natl Acad. Sci. USA 100, 6487-6492 (2003).
48. Zhou, S. et al. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl Acad. Sci. USA 99, 12339-12344 (2002).
49. Alvi, A. J. et al. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res. 5, R1-R8 (2002). The first demonstration of side population in human breast epithelium.
50. Gudjonsson, T. et al. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 16, 693-706 (2002).
51. Chepko, G. & Smith, G. H. Mammary epithelial stem cells: our current understanding. J. Mammary Gland Biol. Neoplasia 4, 35-52 (1999).
52. Reya, T. et al. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
53. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 6890 (2003). Describes the prospective isolation of candidate breast-tumour stem cells.
54. Perez-Losada, J. & Balmain, A. Stem-cell hierarchy in skin cancer. Nature Rev. Cancer 3, 434-443 (2003).
55. Boulanger, C. A. & Smith, G. H. Reducing mammary cancer risk through premature stem cell senescence. Oncogene 20, 2264-2272 (2001).
56. Russo, J. & Russo, I. H. Differentiation and breast cancer. Medicina 57, S81-S91 (1997).
57. Russo, J. et al. Influence of age and parity on the development of the human breast. Breast Cancer Res. Treat. 23, 211-218 (1992).
58. Layde, P. M. et al. The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and steroid hormone study group. J. Clin. Epidemiol. 42, 963-973 (1989).
59. Chie, W. C. et al. Age at any full-term pregnancy and breast cancer risk. Am. J. Epidemiol. 151, 715-722 (2000).
60. Musey, V. C. et al. Long term effects of a first pregnancy on the hormonal environment: estrogens and androgens. J. Clin. Endocrinol. Metab. 64, 111-118 (1987).
61. Musey, V. C. et al. Long-term effect of a first pregnancy on the secretion of prolactin. N. Engl. J. Med. 316, 229-234 (1987).
62. Slaughter, D. P. et al. 'Field cancerization' in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6, 963-968 (1953). The original proposal of the field-cancerization concept.
63. Braakhuls, B. J. et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 63, 1727-1730 (2003).
64. Lakhani, S. R. et al. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J. Pathol. 189, 496-503 (1999).
65. Stappenbeck, T. S. et al. Molecular features of adult mouse small intestinal epithelial progenitors. Proc. Natl Acad. Sci. USA 100, 1004-1009 (2003).
66. Ramalho-Santos, M. et al. 'Stemness': transcriptional profiling of embryonic and adult stem cells. Science 298, 597-600 (2002).
67. Ivanova, N. B. et al. A stem cell molecular signature. Science 298, 601-604 (2002). References 65-67 describe comparative gene-profile expression studies of different stem-cell types.
68. Alexander, C. M. et al. Syndecan-1 is required for Wn1-1-induced mammary tumorigenesis in mice. Nature Genet. 25, 329-332 (2000).
69. Watt, F. M. The stem cell compartment in human interfollicular epidermis. J. Dermatol. Sci. 28, 173-180 (2002).
70. Rosner, A. et al. Pathway pathology: histological differences between ErbB/Ras and wnt pathway transgenic mammary tumors. Am. J. Pathol. 161, 1087-1097 (2002).
71. Lewis, J. Notch signalling and the control of cell fate choices in vertebrates. Semin. Cell Dev. Biol. 9, 583-589 (1998).
72. Brunner, H. G. et al. P63 gene mutations and human developmental syndromes. Am. J. Med. Genet. 112, 284-290 (2002).
73. Lin, H. The stem-cell niche theory: lessons from flies. Nature Rev. Genet. 3, 931-940 (2002).
74. Nishimura, E. K. et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416, 854-860 (2002).
75. Kai, T. & Spradling, A. An empty Drosophila stem cell niche reactivates the proliferation of ectopic cells. Proc. Natl Acad. Sci. USA 100, 4633-4638 (2003).
76. Barcellos-Hoff, M. H. & Ravani, S. A. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60, 1254-1260 (2000).
77. De Ome, K. B. et al. Development of mammary tumours from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 78, 515-520 (1959).
78. Cairns, J. Mutation selection and the natural history of cancer. Nature 255, 197-200 (1975).
79. Potten, C. S. et al. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J. Cell Sci. 115, 2381-2388 (2002).
80. Merok, J. R. et al. Cosegregation of chromosomes containing. immortal DNA strands in cells that cycle with asymmetric stem cell kinetics. Cancer Res. 62, 6791-6795 (2002).